CD44 and neoplasm: For the specific case of HNSCC, CD44+ CSCs were reported to represent a minority population of less than 10% of the tumour cells in human primary carcinomas and did hold stem cell-like properties, i.e. self-renewal and pluripotency to some degree [15], [16].